Sepio Capital LP trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 1.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,945 shares of the medical equipment provider’s stock after selling 41 shares during the quarter. Sepio Capital LP’s holdings in Intuitive Surgical were worth $2,059,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in ISRG. M.E. Allison & CO. Inc. purchased a new position in Intuitive Surgical in the 4th quarter valued at approximately $449,000. Seilern Investment Management Ltd acquired a new position in shares of Intuitive Surgical during the 4th quarter worth $82,517,000. Sycomore Asset Management boosted its position in shares of Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after buying an additional 4,079 shares in the last quarter. Exome Asset Management LLC grew its stake in Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after acquiring an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. increased its holdings in Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after acquiring an additional 525 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
ISRG has been the subject of a number of recent research reports. Royal Bank of Canada raised their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Raymond James upped their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Citigroup lifted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Finally, Barclays upped their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock valued at $17,691,621 over the last ninety days. Corporate insiders own 0.70% of the company’s stock.
Intuitive Surgical Stock Down 8.7 %
ISRG stock opened at $451.58 on Friday. The company has a market capitalization of $160.84 billion, a PE ratio of 70.45, a P/E/G ratio of 5.85 and a beta of 1.55. The stock’s 50 day moving average is $545.18 and its two-hundred day moving average is $532.64. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- Want to Profit on the Downtrend? Downtrends, Explained.
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- Profitably Trade Stocks at 52-Week Highs
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Spotify Stock Eyes Double-Digit UpsideāIs Now the Time to Buy?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.